MICHAEL E RYTTING to Sirolimus
This is a "connection" page, showing publications MICHAEL E RYTTING has written about Sirolimus.
Connection Strength
0.093
-
Preliminary experience with personalized and targeted therapy for pediatric brain tumors. Pediatr Blood Cancer. 2012 Jul 15; 59(1):27-33.
Score: 0.072
-
Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimus. Anticancer Res. 2014 Apr; 34(4):1939-45.
Score: 0.021